STSS (STSS)
Sharps Technology, Inc.
NASDAQ:STSSHealthcare · Medical - Instruments & Supplies
Mkt Cap-
Float-
O/S-
Inst Own-
Dilution
Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
SectorHealthcare
IndustryMedical - Instruments & Supplies
ExchangeNASDAQ
Country
US
USIPO DateApr 14, 2022
Shares Outstanding-
Float--
Company Overview
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, provides smart-safety syringe products to the healthcare industry.
Its product lines focus on providing waste capabilities that incorporate syringe technologies.
The company, through a digital asset treasury strategy, focuses on accumulating Solana (SOL), the native digital asset of the Solana blockchain.
The company was incorporated in 2017 and is based in Melville, New York.
Leadership
Bo Christiansen, MD
Chairman of the Board
Brenda Baird Simpson
Director
Jason Monroe
Director
Paul K. Danner
Director
Employees
19
Country
US
Sector
Healthcare
Website
sharpstechnology.com
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
No price targets availableRatings Distribution
BUY1
HOLD0
SELL0
TOTAL1
Insider Trading
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Saba Capital Management, L.P. | 10% Owner | Sale | 12.2K | $28.9K | Jan 16, 2026 |
| Saba Capital Management, L.P. | 10% Owner | Sale | 25.0K | $57.5K | Jan 15, 2026 |
| Saba Capital Management, L.P. | 10% Owner | Sale | 77.7K | $174.8K | Jan 14, 2026 |
| Saba Capital Management, L.P. | 10% Owner | Sale | 29.8K | $65.2K | Jan 13, 2026 |
 FalconX Holdings Ltd | 10% Owner | Sale | 192.3K | $377.9K | Jan 12, 2026 |
| FalconX Holdings Ltd | 10% Owner | Sale | 47.3K | $92.9K | Jan 12, 2026 |
Shareholders
--
Institutional
(35)
--
Insiderⓘ
(3)
--
5%+ Owners
(5)
--
Unattributed (incl. retail)ⓘ
Top Shareholders
| Name | Shares | % | Source |
|---|---|---|---|
Solios, Inc. · may incl. warrants· filed Feb 2026 | 10.7M | 14.9% | 13D |
Wei Zhu · joint filing· may incl. warrants· filed Sep 2026 | 4.3M | 9.9% | 13D |
Saba Capital Management, L.P. · also on 13F· joint filing· may incl. warrants· filed May 2026 | 3.1M | 7.0% | 13G |
Electric Capital Partners, LLC | 2.6M | -- | 13F |
Electric Capital Frontier Fund II, LP · also on 13F· may incl. warrants· filed Dec 2025 | 2.2M | 7.0% | 13G |
ParaFi Capital LP | 2.2M | -- | 13F |
Saba Capital Management, L.P. | 1.5M | -- | 13F |
VANGUARD CAPITAL MANAGEMENT LLC | 1.4M | -- | 13F |
Pantera Capital Partners LP | 1.1M | -- | 13F |
Walleye Capital LLC STSSW | 1.0M | -- | 13F |
Sources: 13F, Form 4, 13D/13G
Insiders & Institutional Holders
Insiders
- Saba Capital Management, L.P.10% Owner
- FalconX Holdings Ltd10% Owner
- Ruemler Timothy JamesDirector
- Zhang YuwenChief Investment Officer
- DANNER PAUL KDirector
- Monroe Jason L.Director
- Crescenzo Andrew R.Chief Financial Officer
- Hayes Robert MichaelChief Executive Officer
- Christiansen Soren BoDirector
- Simpson Brenda BairdDirector
Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
SectorHealthcare
IndustryMedical - Instruments & Supplies
ExchangeNASDAQ
CountryUS
USIPO DateApr 14, 2022
Shares Outstanding-
Float--
52-Week Range
Volume
Average Daily Volume--
30d Avg
--
60d Avg
--
90d Avg
--
Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...